RANTES (CCL5), an endogenous ligand of CCR1, has pro-inflammatory effects in animal models of cerebral ischemia, Alzheimer’s disease, and autoimmune encephalomyelitis (EAE) [13–15]. Here, CCL5 is linked to early-onset autosomal dominant Alzheimer disease.